GNCA
Genocea Biosciences, Inc.
GNCA
GNCA
Delisted
GNCA was delisted on the 2nd of June, 2022.
41 hedge funds and large institutions have $38.9M invested in Genocea Biosciences, Inc. in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
40% less capital invested
Capital invested by funds: $65.3M → $38.9M (-$26.4M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
41
Holding in Top 10
1
Calls
$313K
Puts
$88K
Top Buyers
| 1 | +$35K | |
| 2 | +$32K | |
| 3 | +$25K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$24.2K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$16.6K |
Top Sellers
| 1 | -$210K | |
| 2 | -$137K | |
| 3 | -$111K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$67.7K |
| 5 |
JPMPWA
J.P. Morgan Private Wealth Advisors
San Francisco,
California
|
-$24K |